Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Bermejo A
- Cerrillo M
- Ruiz-Alonso M
- Garcia-Velasco JA
Grupos
Abstract
Objective: To use microarray technology to analyze endometrial gene expression after gonadotropin-releasing hormone agonist (GnRH-a) triggering with four different protocols of luteal support in comparison with results obtained after a human chorionic gonadotropin (hCG) trigger. Design: Prospective, randomized, controlled trial. Setting: University-affiliated private assisted-reproduction center. Patient(s): 25 healthy oocyte donors undergoing controlled ovarian stimulation. Intervention(s): On day of final oocyte maturation, randomization to [1] GnRH-agonist triggering and luteal support with oral estradiol (2 mg/8 hours) and vaginal progesterone (200 mg/12 hours), [2] GnRH-a and a daily dose of 150 IU of recombinant LH from oocyte pickup, [3] GnRH-a and a single bolus of 60 mg of recombinant hCG on oocyte pickup, [4] GnRH-a and three doses of 20 mg of recombinant hCG separated by 48 hours, or [5] 250 mg of recombinant hCG for trigger and standard luteal support; with endometrial biopsy samples collected 7 days after triggering. Outcome Measure(s): Gene expression using the Endometrial Receptivity Array ( ERA) and pathway and network analysis of study groups 1-4 compared with controls (group 5). Result(s): The 56 genes in group 1 (25 up-regulated and 31 down-regulated) exhibited altered expression compared with the 36 genes from group 2 (13 up-regulated and 23 down-regulated), 44 from group 3 (28 up-regulated and 16 down-regulated), and 30 (20 up-regulated and 10 down-regulated) from group 4. Conclusion(s): Differences were seen in endometrial gene expression related to the type of ovulation trigger and luteal support. However, gene expression after the GnRH-a trigger and modified luteal support adding LH/hCG activity more closely resembles the pattern seen in the hCG group.
Datos de la publicación
- ISSN/ISSNe:
- 0015-0282, 1556-5653
- Tipo:
- Article
- Páginas:
- 138-
- PubMed:
- 24182413
- Factor de Impacto:
- 1,983 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
FERTILITY AND STERILITY ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 16
Documentos
- No hay documentos
Filiaciones
Keywords
- Endometrial receptivity; gene expression; GnRH agonist; ovarian stimulation
Proyectos y Estudios Clínicos
ESTUDIO DE LA ENFERMEDAD METASTASICA EN EL TEJIDO OVARICO CRIOPRESERVADO DE MUJERES CON CANCER DE MAMA
Investigador Principal: ANTONIO PELLICER MARTÍNEZ
PI08/90483 . INSTITUTO DE SALUD CARLOS III . 2009
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL
CD11/00292 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL
CD12/00568 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
Cita
Bermejo A,Cerrillo M,Ruiz M,BLESA D,SIMÓN C,PELLICER A,Garcia JA. Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression. Fertil Steril. 2014. 101. (1):p. 138-138. IF:4,590. (1).